Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POMAIS (Precision Oncology Molecular Analysis and Information System) is a specialized biotechnology and healthcare technology company focused on advancing precision medicine in oncology. The company provides a comprehensive platform that integrates molecular analysis with clinical data to assist oncologists in making data-driven treatment decisions for cancer patients. By leveraging advanced bioinformatics and a proprietary database of genomic alterations, POMAIS identifies targeted therapies and clinical trial opportunities tailored to the unique molecular profile of an individual's tumor. Their services aim to optimize therapeutic outcomes and streamline the implementation of personalized cancer care in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on POMAIS.